Abstract
Background
Dengue is the most rapidly spreading mosquito-borne viral disease in the world. Dengue fever (DF) with its severe manifestations such as dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) has emerged as a major public health problem of international concern. Thrombocytopenia and bleeding are common complications of dengue fever, hence besides platelet counts, there is a need to assess the role of mean platelet volume.
Aims
Studying association of mean platelet volume (MPV) with severity, serology & treatment outcome to assess its prognostic utility, which can be of great help in limiting morbidity & mortality associated with dengue fever.
Materials and Methods
The present study was conducted in Central Pathology Lab of SMS Medical College & Hospital, Jaipur, Rajasthan from the period of March 2013 till October 2013. Blood samples were collected from 200 patients with NS 1 Antigen positivity experiencing febrile illness, clinically consistent with dengue infection. Evaluation of platelet counts, MPV, IgM and IgG antibodies was done in all these cases.
Statistical Analysis
Categorical data were presented as numbers (percent) and were compared among groups using Chi-square test. Groups compared for demographic data were presented as mean and standard deviation and were compared using student t-test, ANOVA and Post-Hoc Test, Tukey Test using SPSS, version 20 for Windows.
Results
A total of 200 Dengue fever cases were studied. Out of which, 68% cases were of DF, 23% DHF & 9% DSS i.e. classical dengue fever was most common presentation. Maximum (44%) cases were in age group of 15-24 years. Fever was the presenting complaint in all cases (100%). 98% cases of dengue had thrombocytopenia. MPV showed no significant correlation with severity, serology & treatment outcome, thus excluding its role in dengue cases.
Conclusion
Mean platelet volume is not important as prognostic parameter in dengue fever.
Keywords: Acute febrile disease, Dengue haemorrhagic fever (DHF), Dengue shock syndrome (DSS), Thrombocytopenia
Introduction
Dengue fever (DF) is an acute febrile disease characterized by sudden onset of fever of 3-5 days, intense headache, myalgia, joint pain, retro-orbital pain, anorexia, gastrointestinal disturbances and rash [1]. It is one of the most important mosquito-borne viral diseases in the world [2]. In the last 50 years, incidence has increased 30-fold with increasing geographic expansion to new countries and, in the present decade, from urban to rural settings [2]. Currently dengue causes about 100 million asymptomatic cases and 25 thousand deaths annually. Infection can be asymptomatic or cause a range of severity from mild dengue fever to dengue haemorrhagic fever which can then progress to dengue shock syndrome and death [1].
Incidence of Dengue fever (DF) and its severe manifestations, dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) is found to be increasing [3]. At present 2.5-3 billion persons living in tropics and subtropics are susceptible for dengue [4].
Dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) are life threatening reversible vascular complications of DF and are associated with severe thrombocytopenia, bleeding and increased vascular permeability [5]. The decreasing platelet counts have found to predict the severity of the disease [6]. So there is a need to study platelets profile & know its prognostic importance so that adverse outcomes of this rapidly spreading disease can be controlled to a great extent. In addition, the bleeding severity has not been well studied in India, especially in relation to platelet function. A common surrogate marker of bleeding can be mean platelet volume (MPV) which is often used to indicate platelet activation and indirectly bone marrow activity [7]. Not much work has been done on this parameter related to dengue fever. Hence this study has been conducted to know association of mean platelet volume (MPV) with severity, serology and treatment outcome which can be of great help in limiting morbidity and mortality associated with dengue fever.
Materials and Methods
The present study was conducted in Central Pathology Lab of SMS Medical College & Hospital, Jaipur, Rajasthan (India) from the period of March 2013 till October 2013. A total of 200 patients admitted to the hospital with the clinical features of dengue fever (selected according to WHO criteria) and NS 1 Antigen positivity in age group between 15-60 years were selected. They were followed from the day of admission till they recovered clinically & were discharged or suffered complications & succumbed to death.
Who Criteria
Clinical Criteria for Diagnosis of Dengue Fever
Dengue fever- Classical dengue fever is an acute febrile viral disease frequently presenting with two or more of the following- headache, bone or joint pain, muscular pain, retro-orbital pain, rash & leucopenia.
Dengue haemorrhagic fever- all must be present:-
1. Fever, or recent history of acute fever.
2. Haemorrhagic manifestations
3. Thrombocytopenia (100,000/mm3 or less).
4. Evidence of plasma leakage due to increased capillary permeability manifested by one or more of the following:
>20% rise in haemotocrit for age and sex.
>20% drop in haemotocrit following treatment with fluids as compared to baseline.
Signs of plasma leakage (pleural effusion, ascites or hypoproteinaemia).
Dengue shock syndrome- Four criteria for Dengue Haemorrhagic Fever with signs of circulatory failure.
NS1 Antigen in serum was detected by ELISA technique using ELISA kit of Panbio company as per manufacturer’s instructions. Following investigations were done- Complete blood counts (CBC), peripheral blood film examination (PBF), IgM and IgG antibody detection. IgM & IgG were detected by kits based on rapid, solid phase in vitro immunochromatographic test, of SD (Standard Diagnostics) company. It is based on principle of antigen-antibody reaction. Samples were run in automated Haematology analyser Sysmex XP 100, 3-Part Differential Haematology Analyser by Transasia to obtain complete blood counts. This gives us platelet counts & mean platelet volume. Automated Haematology analysers work mainly on principle of either aperture impedance or light scattering (flow cytometry) technology. Others include fluorescence and light absorption techniques.
Platelets are counted in whole blood using principle of electrical impedance or electro-optical detection techniques. MPV is also derived by electrical impedance technique. Clinical features, platelet counts & mean platelet volume of selected patients were recorded daily. (Normal Mean Platelet Volume – 8-12 fl in Sysmex XP-100 3-Part Differential Haematology Analyser)
Statistical Analysis
Statistical analysis was performed with the SPSS, version 20 for Windows statistical software package (SPSS inc., Chicago, il, USA). The Categorical data were presented as numbers (percent) and were compared among groups using Chi square test. Groups compared for demographic data were presented as mean and standard deviation and were compared using student t-test, ANOVA Test and Post-Hoc Test Tukey Test to find out the most significant group among all the groups. Probability p-value <0.05 was considered statistically significant.
Results
Out of total 200 dengue cases, commonest presentation was dengue fever (DF) (68%) followed by dengue haemorrhagic fever (DHF) (23%) and least were dengue shock syndrome (DSS) (9%). Males were in higher proportion as compared to females (with males 63.5% and 36.5% females) and M:F = 1.7:1. No significant difference was observed according to sex with severity of the cases. Cases of dengue were highest in 15 to 24 age group (younger age group). Proportion of cases decreased as age increased. The mean age of study group was 28.59±10.34 years with range 15 to 60 years [Table/Fig-1].
[Table/Fig-1]:
Age group wise distribution with severity
| AGE (in years) | Total | DF | DHF | DSS | ||||
|---|---|---|---|---|---|---|---|---|
| Number | % | Number | % | Number | % | Number | % | |
| 15-24 | 88 | 44 | 51 | 37.5 | 25 | 54.35 | 12 | 66.67 |
| 25-34 | 62 | 31 | 45 | 33.09 | 13 | 28.26 | 4 | 22.22 |
| 35-44 | 28 | 14 | 27 | 19.85 | 1 | 2.17 | 0 | 0.00 |
| 45-54 | 15 | 7.5 | 7 | 5.15 | 6 | 13.04 | 2 | 11.11 |
| >= 55 | 7 | 3.5 | 6 | 4.41 | 1 | 2.17 | 0 | 0 |
| 200 | 100 | 136 | 100 | 46 | 100 | 18 | 100 | |
Chi-square = 20.106 with 8 degrees of freedom; Probability p = 0.010, Significant
Fever was the presenting complain in all cases (100%). Except only 4 cases, all (196/200) i.e. 98% dengue cases had thrombocytopenia throughout the course of illness.
Higher proportion (61.11%) (11/18) with 8 to 12 fL MPV were presented with DSS when compared to those with <8 fL MPV. Higher proportion (55.15%) (75/136) of dengue fever and 56.52% (26/46) of DHF cases were in >12 MPV range. However, No significant difference was observed in Mean platelet volume with severity of disease [Table/Fig-2].
[Table/Fig-2]:
Mean platelet volume with severity
| MPV (fL) (corres-ponding to minimal platelet counts)* |
Total | DF | DHF | DSS | Chi-square test | |||
|---|---|---|---|---|---|---|---|---|
| Number | Number | % | Number | % | Number | % | ||
| <8 | 2 | 1 | 0.74 | 1 | 2.17 | 0 | 0 | 2.959 with 4 df; p=0.565 Not Significant (NS) |
| 8 to 12 | 90 | 60 | 44.12 | 19 | 41.3 | 11 | 61.11 | |
| >12 | 108 | 75 | 55.15 | 26 | 56.52 | 7 | 38.89 | |
| Total | 200 | 136 | 100 | 46 | 100 | 18 | 100 | |
|
MPV (fL) at day of discharge |
Number | Number | % | Number | % | Number | % | |
| <8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.305 with 2 df; p = 0.859 NS |
| 8 to 12 | 78 | 53 | 38.97 | 17 | 37 | 8 | 44.4 | |
| >12 | 122 | 83 | 61.03 | 29 | 63 | 10 | 55.6 | |
| Total | 200 | 136 | 100 | 46 | 100 | 18 | 100 | |
*MPV is corresponding to the lowest platelet counts of the patient, attained during his/her course of illness (before day of discharge)
NS - Not Significant df – degree of freedom
The mean MPV in DF, DHF and DSS was 0.39±2.022, 0.59±1.99 and 0.51±2.069 respectively but no significant difference was observed in Mean difference between MPV at the time of Minimal Platelet counts and at the time of discharge among spectrum of Dengue illness. (p=0.837 Not Significant) (ANOVA) [Table/Fig-3].
[Table/Fig-3]:
Association of mean difference in mean platelet volume with severity of the disease
| SEVERITY | NUMBER | MEAN | STD. DEVIATION | ANOVA |
|---|---|---|---|---|
| DF | 136 | .39 | 2.022 | |
| DHF | 46 | .59 | 1.994 | |
| DSS | 18 | .51 | 2.069 | |
| Total | 200 | .45 | 2.012 | 0.837 NS |
No significant relation was observed between IgM, IgG antibodies and serology with MPV (fL) (corresponding to minimal platelet counts attained during the course of illness) [Table/Fig-3].
Also, no significant relation was observed between IgM, IgG antibodies and serology with MPV (fL), at the time of discharge [Table/Fig-4].
[Table/Fig-4]:
Mean platelet volume with serology
| MPV (fL) (corres-ponding to minimal platelet counts) |
Total | IgM | IgG | Sero Negative |
Sero- Positive |
||
|---|---|---|---|---|---|---|---|
| - | + | - | + | ||||
| <8 | 2 | 0 | 2 | 0 | 2 | 0 | 2 |
| 8 to 12 | 90 | 12 | 78 | 17 | 73 | 4 | 86 |
| >12 | 108 | 9 | 99 | 17 | 91 | 3 | 105 |
| Total | 200 | 21 | 179 | 34 | 166 | 7.00 | 193 |
| 1.54 with 2 df | 0.75 with 2df | 0.47 with 2 df | |||||
| 0.46 NS | 0.75 NS | 0.47 NS | |||||
|
MPV (fL) at day of discharge |
Total | IgM | IgG |
Sero Negative |
Sero- Positive |
||
| - | + | - | + | ||||
| <8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 8 to 12 | 78 | 11 | 67 | 15 | 63 | 5 | 73 |
| >12 | 122 | 10 | 112 | 19 | 103 | 2 | 120 |
| Total | 200 | 21 | 179 | 34 | 166 | 7 | 193 |
| 1.19 with 1df | 0.23 with 1 df | 1.95 with 1 df | |||||
| 0.275 NS | 0.229 NS | 1.95 NS | |||||
No significant difference was observed while correlating mean platelet volume with the treatment outcome. No significant difference was observed in Mean between MPV at the time of Minimal Platelet counts and at the time of discharge except in dengue fever cases [Table/Fig-5].
[Table/Fig-5]:
Association of mean of MPV with treatment outcome
| OUTCOME | NUMBER | MEAN of MPV | SD | p-value |
|---|---|---|---|---|
| DEATH | ||||
| MPV corresponding to minimal platelet counts | 6 | 11.42 | 1.455 | 0.158 NS |
| At discharge | 6 | 10.47 | 0.450 | |
| RECOVERY (DF) | ||||
| MPV corresponding to minimal platelet counts | 136 | 11.93 | 1.557 | 0.029 S* |
| At discharge | 136 | 12.32 | 1.361 | |
| RECOVERY (DHF) | ||||
| MPV corresponding to minimal platelet counts | 45 | 11.91 | 1.831 | 0.068 NS |
| At discharge | 45 | 12.51 | 1.174 | |
| RECOVERY (DSS) | ||||
| MPV corresponding to minimal platelet counts | 13 | 11.29 | 1.740 | 0.06 NS |
| At discharge | 13 | 12.47 | 1.289 | |
*S - Significant
Discussion
Dengue fever is a growing public health concern in most tropical countries [1]. In India, epidemics are becoming more frequent [2]. A total of 200 patients admitted to our hospital with the clinical features of dengue fever (according to WHO criteria) and NS1 Antigen positivity were studied.
Incidence of DF, DHF and DSS was 68%, 23% and 9% respectively. The present study included more in (63.5%) male & (36.5%) female patients, M:F=1.7:1 correspontding to the study by K Jayashree et al., (1.39:1) and Dash PK et al., (1.28:1) [6,8]. Cases were highest in 15 to 24 years age group. This was corresponding to the other studies by PM Ukey et al., and D Cecilia et al., in which maximum cases were noted in 15-30 years & 21-30 years respectively [9,10]. Fever was the presenting complain in all cases.
The association of thrombocytopenia with dengue infection has been proved to be significant (p<0.001). A total of 98% patients had thrombocytopenia. Study by M. Anuradha et al., showed thrombocytopenia in 89% of total patients [11].
No significant difference was observed in MPV with severity of diseases. In the study done by Dewi et al., there was no significant difference in MPV between DF, DHF and DSS (9.18±1.5 fL vs. 8.94±1.94 fL vs. 8.57±1.03 fL, p=0.761) [7]. Wiwanitkit et al., found that MPV for patients with DHF is not decreased & appears to be similar to that for the general healthy population [12].
No significant relation was observed between IgM, IgG antibodies and serology (seropositive or seronegative) with MPV (fL) (corresponding to minimal platelet counts attained during the course of illness). No significant relation was observed between them even at the time of discharge.
No significant difference was observed in Mean between MPV at the time of minimal platelet counts and at discharge in dengue cases except in dengue fever cases. This correlated with study done by Dewi et al & Viroj Wiwanitkit et al., [7,12].
Conclusion
A total of 200 patients admitted to the hospital with the clinical features of dengue fever (according to WHO criteria) and NS1 Antigen positivity were studied in our study. Present study had an objective of studying mean platelet volume in association with severity, serology & treatment outcome to assess its prognostic utility. MPV showed no significant correlation with severity, serology & treatment outcome, thus excluding its role in dengue cases. Mean platelet volume has not found to be an important prognostic parameter in dengue fever cases.
Financial or Other Competing Interests
None.
References
- [1].Restrepo BN, Piedrahita LD, Agudelo IY, Parra-Henao G, Osorio JE. Frequency and Clinical Features of Dengue Infection in a School children cohort from Medellin, Colombia. Journal of Tropical Medicine. 2012;120496:1–9. doi: 10.1155/2012/120496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2]. Dengue. Guidelines for diagnosis, treatment, prevention and control, 2nd edition, World Health Organisation, Geneva 2009; 1-144. [PubMed]
- [3]. Global strategy for dengue prevention and control. 2012-2020 ISBN 9789241504034. [Google Scholar]
- [4].Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nature Reviews Microbiology. 2010;8(12):S7–S16. doi: 10.1038/nrmicro2460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Gubler D J. Dengue and dengue Haemorrhagic fever. London, United Kingdom: CAB International; American society of Microbiology; 1997. Dengue and dengue Haemorrhagic fever: its history and resurgence as a global public health problem. In: Gubler D J, Kuno G, editors; pp. 1–22. [Google Scholar]
- [6].Jayashree K, Manasa GC, Pallavi P, Manjunath GV. Evaluation of Platelets as Predictive Parameters in Dengue Fever. Indian J Haematol Blood Transfus. 2011;27(3):127–30. doi: 10.1007/s12288-011-0075-1. DOI 10.1007/s12288-011-0075-71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Dewi YP. Mean Platelet Volume (MPV): Potential Predictor of Disease Severity in Dengue infection. In proceeding of: International Dengue Symposium. 2013 conference paper. [Google Scholar]
- [8].Dash PK, Saxena P, Abhavankar A, Bhargava R, Jana AM. Emergence of dengue virus type 3 in Northern India. Southeast Asian J Trop Med Public Health. 2005;36(2):370–77. [PubMed] [Google Scholar]
- [9].Ukey PM, Bondade SA, Paunipagar PV, Powar RM, Akulwar SL. Study of Seroprevalence of Dengue Fever in Central India. Indian J Community Med. 2010;35(4):517–19. doi: 10.4103/0970-0218.74366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Cecilia D. Current status of dengue and chikungunya in India. WHO South-East Asia. Public Health. 2014;3(1):22–27. doi: 10.4103/2224-3151.206879. [DOI] [PubMed] [Google Scholar]
- [11].Anuradha M, Dandekar RH. Screening and manifestations of seropositive dengue fever patients in perambalur: a hospital based study. International Journal of Medical Science and Public Health. 2014;Vol 3(Issue 6):745–48. [Google Scholar]
- [12].Viroj Wiwanitkit. Mean platelet volume in the patients with dengue hemorrhagic fever. Platelets. 2004;15(3):185. doi: 10.1080/0953710042000199839. [DOI] [PubMed] [Google Scholar]